IKT Inhibikase Therapeutics
- 1.2000
- +0.0397+3.42%
- 1.1990
- -0.0010-0.08%
Inhibikase Therapeutics News
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester
Inhibikase Therapeutics | D: Filing D
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth
Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer FRATTAROLI JOSEPH
Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)
Inhibikase Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Milton H. Werner(19.68%)
Inhibikase Therapeutics | D: Filing D
Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities
Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Dion Gisele
Analysis
Price Target
No Data
No Data